Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407602 · ClinicalTrials.gov registry record · NA
Argus® II Retinal Stimulation System Feasibility Protocol
A NA study, sponsored by Second Sight Medical Products.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00407602 is a NA study that has completed, run by Second Sight Medical Products. The registered enrollment target is 30 participants.
The verdict
NCT00407602, a NA study, has completed, sponsored by Second Sight Medical Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Investigational Phase of the Study: The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with retinitis pigmentosa. Post-Approval Phase of the Study: To collect post-approval data in order to monitor the ongoing safety and reliability of the Argus II System
Interventions
- DEVICE Implant of Argus II Retinal Prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-09 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00407602
The ClinicalTrials.gov registry entry for NCT00407602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Second Sight Medical Products, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implant of Argus II Retinal Prosthesis is the first listed.
NCT00407602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00407602 about?
NCT00407602 is a clinical study titled "Argus® II Retinal Stimulation System Feasibility Protocol". Investigational Phase of the Study: The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with retinitis pigmentosa. Post-Approval Phase of the Study: To collect post-approval data in...
What is the current status of trial NCT00407602?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-09. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT00407602?
The interventions under investigation include: Implant of Argus II Retinal Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT00407602?
This trial is sponsored by Second Sight Medical Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.